MENU
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Exelixis (EXEL) Ownership - Who owns Exelixis?
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.2B
P/E Ratio
18.22
Total Cash
791.1M
Projected Growth
2.62
Total Debt
179.84M
Revenue
2.23B
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash/Share
2.94
Total Debt/Equity
479.87
Revenue/Share
7.71 USD as % of share price
Fundamentals
EXEL
Capitalization
10.2B
P/E Ratio
18.22
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash
791M
Total Cash/Share
2.94
Total Debt
180M
Total Debt/Equity
479.87
Projected Growth (PEG Ratio)
2.62
Revenue/Share (as % of the share price)
7.71%
Revenue
2.23B
ROE
N/A
Book Value
2.03B
P/B Ratio
5.02
Cash Flow
N/A
Earnings
2.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
270K
Current Ratio
3.51
Current Revenue Per Employee
495432.44
Dividends Per Share - Security
N/A
EBITDA
782M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.57
Revenue To Assets
22.10
Shares Held By Institutions
18.2B
Shares Outstanding - Current
269M
Total Liabilities
645M
Total Volume MTD
N/A
Value
-1
Gain YTD
13.814
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EXEL showed earnings on July 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com